Effects of glucose-dependent insulinotropic peptide on osteoclast function
Open Access
- 1 February 2007
- journal article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 292 (2), E543-E548
- https://doi.org/10.1152/ajpendo.00364.2006
Abstract
Acute nutrient ingestion leads to a rapid inhibition of bone resorption while effects on makers of bone formation are less marked or absent, suggesting that there is a transient shift toward skeletal accretion in the immediate postprandial period. The cellular bases for these effects are not clear. Glucose-dependent insulinotropic peptide (GIP), a known modulator of glucose-induced insulin secretion, is secreted from intestinal endocrine cells in response to nutrient ingestion. In addition to the effect of GIP on pancreatic β-cells, GIP receptors are expressed by osteoblastic cells in bone, suggesting a role for this incretin hormone in bone formation. To determine whether GIP also plays a role in the anti-resorptive effect of nutrient ingestion, osteoclasts were analyzed for the presence of GIP receptors by PCR, immunohistochemical and immunocytochemical analyses of bone tissue, and freshly isolated mature osteoclasts and osteoclast-like cells cultured in vitro. Osteoclast function was assessed by fetal long bone resorption assay and by use of the Osteologic disc assay. Our results demonstrate that GIP receptor transcripts and protein are present in osteoclasts. In addition, with the use of an in vitro organ culture system and mature osteoclasts, GIP was found to inhibit bone resorption in the organ culture system and the resorptive activity of mature osteoclasts. These data are consistent with the hypothesis that GIP inhibits bone breakdown through a direct effect on osteoclast-resorptive activity and suggest one mechanism for the postprandial reduction in markers of bone breakdown.Keywords
This publication has 28 references indexed in Scilit:
- Nutrition-Related Peptides and Bone HomeostasisJournal of Bone and Mineral Research, 2006
- Disordered osteoclast formation in RAGE-deficient mouse establishes an essential role for RAGE in diabetes related bone lossBiochemical and Biophysical Research Communications, 2006
- Potential Role of Pancreatic and Enteric Hormones in Regulating Bone TurnoverJournal of Bone and Mineral Research, 2005
- Skeletal involvement in patients with diabetes mellitusDiabetes/Metabolism Research and Reviews, 2004
- Role of Gastrointestinal Hormones in Postprandial Reduction of Bone ResorptionJournal of Bone and Mineral Research, 2003
- Acute Changes of Bone Turnover and PTH Induced by Insulin and Glucose: Euglycemic and Hypoglycemic Hyperinsulinemic Clamp StudiesJournal of Clinical Endocrinology & Metabolism, 2002
- Transcriptional Program of Mouse Osteoclast Differentiation Governed by the Macrophage Colony-stimulating Factor and the Ligand for the Receptor Activator of NFκBJournal of Biological Chemistry, 2002
- Functional GIP Receptors Are Present on AdipocytesEndocrinology, 1998
- Bone Mineral Density and Bone Metabolism in Diabetes MellitusHormone and Metabolic Research, 1997
- Transforming growth factor-β stimulates bone resorption in neonatal mouse calvariae by a prostaglandin-unrelated but cell proliferation-dependent pathwayJournal of Bone and Mineral Research, 1996